After decades of hype and setbacks, scientists have made impressive progress into tricking stem cells into repairing organs.

RENEW Phase 2 trial evaluating the safety, tolerability, and efficacy of LTI-03 in idiopathic pulmonary fibrosis (IPF) initiated with topline interim data expected ...